The three-point MACE risk reduction observed in SELECT suggests the potential for a new option in obesity treatment, addressing some of the leading causes of preventable death worldwide. Analyses of the three components in MACE showed that the risk of non-fatal myocardial infarction or heart attack was reduced by 28% compared to placebo (HR: 0.72
Reputable peptide cosmetic manufacturers buffer their formulations to pH 5.5 and include chelating agents (EDTA or citric acid) to stabilise the copper complex
We compared them honestly: head-to-head trial results, side effects, switching, and how Ali actually chooses
Join us as we uncover the truth
Only about 25% of commercial plans approve semaglutide for obesity, and those typically require documented diabetes diagnosis first
Earlier this week, the question of whether NRL players are cutting corners with weight-loss jabs was asked